From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...
The Phase 1b/2 SCLC trial and Phase 2 VIRO-25 trial are actively enrolling in dose escalation cohorts with an aim to optimize efficacy, safety, and tolerability of Olvi-Vec. The trials are being ...
A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...
The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...
Hospital Sisters Health System is using artificial intelligence to help catch lung cancer earlier, but sometimes before ...
Lung cancer remains a severe malignancy, expected to account for over 125,000 deaths in 2024. With high rates of mortality in both males and females, lung cancer accounts for more cancer-related ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback